Literature DB >> 22329775

Value of two-dimensional speckle tracking and real time three-dimensional echocardiography for the identification of subclinical left ventricular dysfunction in patients referred for routine echocardiography.

Samir K Saha1, Anatoli Kiotsekoglou, Rena S Toole, James C Moggridge, Kenneth J Nichols, Satish Govind, Aasha S Gopal.   

Abstract

BACKGROUND: While speckle tracking echocardiography (2DSTE) can be used to study longitudinal, circumferential, and radial function, real time 3D echocardiography (3DE) generates dynamic time-volume curves, offering a wide array of new parameters for characterizing mechanical and volumetric properties of the left ventricle (LV). Our aim was to investigate the merit of these new techniques to separate normal from abnormal echocardiograms as well as to identify subclinical disease in reportedly normal subjects.
METHODS: Eighty-one patients (mean age 61 ± 16 years) underwent standard 2D echocardiography (2DE) enhanced by 2DSTE and 3DE. The data included LV volumes and ejection fraction (EF), velocities, strain/strain rate, and peak ejection/filling rates. The patients were divided into Group 1: normal (n = 42) and Group 2: abnormal (n = 39) on the basis of an expert interpretation of the resting 2DE.
RESULTS: Global longitudinal strain (%) was 17 ± 4 in Group1 and 14 ± 4 in Group2 (P < 0.002). Strain rates (SR, 1/sec) at peak systole (1.1 ± 0.2 vs 0.9 ± 0.3, P < 0.001) and early diastole (1.3 ± 0.3 vs 0.9 ± 0.3, P < 0.001) were also higher in Group1. Three-dimensional peak ejection and filling rates (EDV/sec) were significantly higher in Group1 (-2.5 ± 0.4 vs -2.1 ± 0.7, and 1.8 ± 0.2 vs 1.5 ± 0.5, P < 0.002, P < 0.001, respectively). The best discriminatory power for predicting a normal 2DE was systolic SR with a sensitivity of 82% and a specificity of 54% using a cutoff value of 1.09. Interestingly, 19/41 (46%) of Group1 patients had systolic SR < 1.09, suggesting subclinical disease.
CONCLUSIONS: 2DSTE and 3DE can discriminate between normal and abnormal echocardiograms and have the potential to detect subclinical LV dysfunction.
© 2012, Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22329775     DOI: 10.1111/j.1540-8175.2011.01631.x

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  6 in total

Review 1.  Non-invasive evaluation of arrhythmic risk in dilated cardiomyopathy: From imaging to electrocardiographic measures.

Authors:  Massimo Iacoviello; Francesco Monitillo
Journal:  World J Cardiol       Date:  2014-07-26

2.  Early impairment of left ventricular function in patients with systemic hypertension: new insights with 2-dimensional speckle tracking echocardiography.

Authors:  Shantanu P Sengupta; Giuseppe Caracciolo; Caleb Thompson; Haruhiko Abe; Partho P Sengupta
Journal:  Indian Heart J       Date:  2012-12-26

3.  Metabolic syndrome, strain, and reduced myocardial function: multi-ethnic study of atherosclerosis.

Authors:  André Luiz Cerqueira de Almeida; Gisela Teixido-Tura; Eui-Young Choi; Anders Opdahl; Verônica R S Fernandes; Colin O Wu; David A Bluemke; João A C Lima
Journal:  Arq Bras Cardiol       Date:  2014-04       Impact factor: 2.000

4.  Systolic Longitudinal Function of the Left Ventricle Assessed by Speckle Tracking in Heart Failure Patients with Preserved Ejection Fraction.

Authors:  Mehrnoush Toufan; Saeed Mohammadzadeh Gharebaghi; Leili Pourafkari; Elham Delir Abdolahinia
Journal:  J Tehran Heart Cent       Date:  2015-10-27

5.  Ultrasonic image analysis of longitudinal strain in uremic patients with preserved left ventricular ejection fraction.

Authors:  Yuqin Ma; Bo Zhang; Yuzhen Zhang; Yun Dong; Ruiqing Zhang
Journal:  Biomed Eng Online       Date:  2018-08-20       Impact factor: 2.819

6.  Application of strain and other echocardiographic parameters in the evaluation of early and long-term clinical outcomes after cardiac surgery revascularization.

Authors:  Anna Gozdzik; Krzysztof Letachowicz; Barbara Barteczko Grajek; Tomasz Plonek; Marta Obremska; Marek Jasinski; Waldemar Gozdzik
Journal:  BMC Cardiovasc Disord       Date:  2019-08-05       Impact factor: 2.298

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.